Radiation therapy for advanced lung cancer with many metastases
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether aiming radiation at the main lung tumor can help people with advanced lung cancer that has spread to many places. It is for people who have not had much treatment yet or whose cancer is currently stable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage IV non-small cell lung cancer with more than 5 separate spots of cancer spread (not just a few).
- You have not had any cancer treatment yet, or you have had some treatment (like targeted pills, chemotherapy, or immunotherapy) and the cancer is currently under control.
- You are between 18 and 80 years old and are in fairly good health (able to do most daily activities).
- Your lung function is good enough (FEV1 > 50%), and your major organs (heart, liver, kidneys, blood) are working well.
- If cancer has spread to your brain, you are awake and alert.
- You are willing to follow the study plan and give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
This trial tests a new approach for advanced non-small cell lung cancer that cannot be surgically removed. It combines a focused, high-dose radiation treatment to the tumor core followed by standard chemotherapy and radiation together. This may help fight the cancer more effectively.
This trial tests whether giving radiation to the main lung tumor, along with standard therapy (like chemo or immunotherapy), helps people with newly diagnosed stage IV lung cancer live longer. It is for people whose cancer does not have certain gene changes (EGFR, ALK, ROS1) and who have tumors in only a few other organs.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial explores whether combining radiation therapy with immunotherapy can trigger an immune response that shrinks tumors throughout the body (abscopal effect) in people with non-small cell lung cancer that has spread to 3 to 6 other sites. It tests different patterns of these treatments to see which works best.
This early study tests whether a specific kind of radiation can be safely given to people with newly diagnosed metastatic lung cancer when cure isn’t possible. It’s meant to see how well the treatment can be delivered and how it affects outcomes in a specific genetic group of tumors.
Hear when a new Non Small Cell Lung Cancer Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.